Back to results
US 2024/0123012 A1Published application
Therapeutic composition based on dhodh-inhibiting neurolaena leaves for the treatment of rna virus infections
AssigneePhytobokaz
InventorHenry JOSEPH
Life of this patent
Estimating the term…
Abstract
A therapeutic composition includes a mother tincture of a leaf extract of a plant of the genus “Neurolaena” and the species “lobata” for use as a drug inhibiting human dihydroorotate dehydrogenase (DHODH).
Claims8
A therapeutic composition comprising:
- a mother tincture of a leaf extract of a plant of the genus “Neurolaena” and the species “lobata” for use as a drug inhibiting human dihydroorotate dehydrogenase (DHODH) in the treatment of a viral infection of RNA-genome virus,
- wherein said RNA-genome virus is selected from viruses from the following list:
- the viruses of the Coronaviridae family,
- the virus responsible for hepatitis C, the virus responsible for yellow fever or the Zika virus in the Flaviviridae family,
- the virus responsible for chikungunya in the Togaviridae family.
2 more elements
A method for preparing a dry extract of a diluted mother tincture of dried leaves of Neurolaena lobata, the method comprising the following steps:
- i) preparing a mixture of dried leaves of Neurolaena lobata in sugar cane alcohol at 50°, said mixture having a mass concentration of between 15 and 20 g/L;
- ii) macerating said mixture under agitation for about 21 days;
- iii) filtering, after the step of macerating, the mixture on “cartridges” of porosity 50-75 μm and a liquid filtrate is obtained, corresponding to a mother tincture of dried leaves of Neurolaena lobata, and a solid retentate;
- iv) diluting said liquid mother tincture to ¼ by adding an aqueous solution, and an aqueous-alcoholic solution is thus obtained;
- v) evaporating the alcohol contained in this solution by a rotary evaporator, until an aqueous solution is obtained;
- and
- vi) consolidating and freeze-drying the aqueous solution thus obtained to obtain a dry extract of the diluted mother tincture of dried leaves of Neurolaena lobata.
4 more elements
A diluted mother tincture extract of dried leaves of Neurolaena lobata, comprising:
- diluted to ¼ of the mother tincture, and freeze-dried, said extract being in a solution and having a final concentration of between 6,500 and 20,000 ng/mL (mass of freeze-dried dry extract of diluted mother tincture/volume of aqueous solution), for its use in the treatment of a viral infection due to the SARS-CoV-2 virus responsible for Covid-19.
Dependencies are inferred from the claim text.